3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Lymphoma
16
Multiple Myeloma
13
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
10
Melanoma
9
Lung Neoplasms
9
Prostatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphoma, Non-Hodgkin
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Neuroblastoma
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, Follicular
4
Burkitt Lymphoma
4
Wilms Tumor
3
Small Cell Lung Carcinoma
3
Sarcoma, Kaposi
3
Sarcoma
3
Rhabdoid Tumor
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Osteosarcoma
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
3
Medulloblastoma
3
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Biopsy
×
Clear all
No trials found.